Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
+2.53M
-
Total reported value, excl. options
-
$1.64B
-
Value change
-
+$59.8M
-
Put/Call ratio
-
0.34
-
Number of buys
-
104
-
Number of sells
-
-79
-
Price
-
$37.55
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2017
236 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2017.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
of 44.9M outstanding shares and own 96.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.32M shares), VANGUARD GROUP INC (3.17M shares), HealthCor Management, L.P. (2.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.79M shares), Consonance Capital Management LP (1.38M shares), venBio Select Advisor LLC (1.31M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.29M shares), DARUMA CAPITAL MANAGEMENT LLC (1.22M shares), MACQUARIE GROUP LTD (1.15M shares), and PointState Capital LP (1.14M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.